Literature DB >> 15591622

PI3K/AKT signaling and systemic autoimmunity.

Rahul K Patel1, Chandra Mohan.   

Abstract

The phosphoinositide 3-kinase (PI3K)/Akt signaling axis plays an important role in cellular proliferation and growth signaling. With respect to the immune system, a growing body of data is helping to elucidate the role of this pathway in lymphocyte development, as well as to show how perturbations that lead to unregulated activation in this pathway may produce systemic autoimmunity or malignancy. Various knockout and transgenic murine models have been described for key mediators of this signaling pathway. Many of these models resulting in the activation of this pathway demonstrate features of systemic autoimmunity, linking this pathway to autoimmune disease. Here, we review recently described murine models that exhibit activated PI3K/Akt signaling and the potential role this pathway in autoimmune disease, and also discuss the therapeutic implications of these findings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15591622     DOI: 10.1385/IR:31:1:47

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  46 in total

1.  Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase.

Authors:  Lei Bi; Ichiro Okabe; David J Bernard; Robert L Nussbaum
Journal:  Mamm Genome       Date:  2002-03       Impact factor: 2.957

Review 2.  The role of PI3K in immune cells.

Authors:  Shigeo Koyasu
Journal:  Nat Immunol       Date:  2003-04       Impact factor: 25.606

3.  Acute pathological effects on rats of orally administered wortmannin-containing preparations and purified wortmannin from Fusarium oxysporum.

Authors:  R Gunther; H K Abbas; C J Mirocha
Journal:  Food Chem Toxicol       Date:  1989-03       Impact factor: 6.023

4.  Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha.

Authors:  R L Tuttle; N S Gill; W Pugh; J P Lee; B Koeberlein; E E Furth; K S Polonsky; A Naji; M J Birnbaum
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

5.  Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene.

Authors:  W S Chen; P Z Xu; K Gottlob; M L Chen; K Sokol; T Shiyanova; I Roninson; W Weng; R Suzuki; K Tobe; T Kadowaki; N Hay
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

6.  Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.

Authors:  V Stambolic; A Suzuki; J L de la Pompa; G M Brothers; C Mirtsos; T Sasaki; J Ruland; J M Penninger; D P Siderovski; T W Mak
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

7.  Pten is essential for embryonic development and tumour suppression.

Authors:  A Di Cristofano; B Pesce; C Cordon-Cardo; P P Pandolfi
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

8.  Immunosuppressive effects of dietary wortmannin on rats and mice.

Authors:  R Gunther; P N Kishore; H K Abbas; C J Mirocha
Journal:  Immunopharmacol Immunotoxicol       Date:  1989       Impact factor: 2.730

Review 9.  Tor signalling in bugs, brain and brawn.

Authors:  Estela Jacinto; Michael N Hall
Journal:  Nat Rev Mol Cell Biol       Date:  2003-02       Impact factor: 94.444

10.  mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo.

Authors:  Chang-Hyuk Kwon; Xiaoyan Zhu; Junyuan Zhang; Suzanne J Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-08       Impact factor: 11.205

View more
  28 in total

1.  Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.

Authors:  Valentina Di Caro; Antonella D'Anneo; Brett Phillips; Carl Engman; Jo Harnaha; Massimo Trucco; Nick Giannoukakis
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 2.  Myeloid disorders after autoimmune disease.

Authors:  Prajwal C Boddu; Amer M Zeidan
Journal:  Best Pract Res Clin Haematol       Date:  2019-02-07       Impact factor: 3.020

3.  Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders.

Authors:  Milad Riazifar; M Rezaa Mohammadi; Egest J Pone; Ashish Yeri; Cecilia Lässer; Aude I Segaliny; Laura L McIntyre; Ganesh Vilas Shelke; Elizabeth Hutchins; Ashley Hamamoto; Erika N Calle; Rossella Crescitelli; Wenbin Liao; Victor Pham; Yanan Yin; Jayapriya Jayaraman; Jonathan R T Lakey; Craig M Walsh; Kendall Van Keuren-Jensen; Jan Lotvall; Weian Zhao
Journal:  ACS Nano       Date:  2019-05-29       Impact factor: 15.881

Review 4.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

5.  Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus.

Authors:  Samuel K Shimp; Cristen B Chafin; Nicole L Regna; Sarah E Hammond; Molly A Read; David L Caudell; Marissanichole Rylander; Christopher M Reilly
Journal:  Cell Mol Immunol       Date:  2012-04-30       Impact factor: 11.530

6.  Sjögren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase.

Authors:  Jean S Oak; Jonathan A Deane; Michael G Kharas; Ji Luo; Thomas E Lane; Lewis C Cantley; David A Fruman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-27       Impact factor: 11.205

7.  Gluten affects epithelial differentiation-associated genes in small intestinal mucosa of coeliac patients.

Authors:  K Juuti-Uusitalo; M Mäki; H Kainulainen; J Isola; K Kaukinen
Journal:  Clin Exp Immunol       Date:  2007-09-20       Impact factor: 4.330

Review 8.  Large granular lymphocyte leukemia: from dysregulated pathways to therapeutic targets.

Authors:  Francis Leblanc; Dan Zhang; Xin Liu; Thomas P Loughran
Journal:  Future Oncol       Date:  2012-07       Impact factor: 3.404

9.  Phosphatidylinositol 3-kinase is a key mediator of central sensitization in painful inflammatory conditions.

Authors:  Sophie Pezet; Fabien Marchand; Richard D'Mello; John Grist; Anna K Clark; Marzia Malcangio; Anthony H Dickenson; Robert J Williams; Stephen B McMahon
Journal:  J Neurosci       Date:  2008-04-16       Impact factor: 6.167

10.  Autism, asthma, inflammation, and the hygiene hypothesis.

Authors:  Kevin G Becker
Journal:  Med Hypotheses       Date:  2007-04-06       Impact factor: 1.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.